08:56 AM EDT, 07/14/2025 (MT Newswires) -- Journey Medical ( DERM ) said Monday that 65% of the 187 million commercial lives in the U.S. now have pharmacy benefit coverage for Emrosi, its recently launched treatment for inflammatory lesions of rosacea in adults.
The company said it marks an increase from 29% coverage in May.